News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ariad Pharmaceuticals, Inc. (ARIA) Sinks Some More as Sales of Blood Cancer Drug are Suspended


10/31/2013 8:24:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ariad Pharmaceuticals Inc. (ARIA) plummeted as much as 43 percent as the company temporarily suspended sales of its only drug Iclusig for patients with certain forms of leukemia. Ariad fell 38 percent to $2.47 at 9:44 a.m. in New York, after plunging to $2.27, the lowest intraday price since February 2010. The U.S. Food and Drug Administration requested the halt yesterday, Cambridge, Massachusetts-based Ariad said today in a statement.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at ABC News
Read at Xconomy
Read at News-Medical


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES